Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of Translational Medicine|April 16, 2023
Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplayXueying Fan, Mingjing Meng, Baoting Li, et al.
Cellular and Molecular Life Sciences : CMLS|October 28, 2022
Omics approach to reveal the effects of obesity on the protein profiles of the exosomes derived from different adipose depotsMinting Chen, Fan Zhang, Baisen Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 12, 2022
Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future PerspectivesJayaprakasam Bolleddula, Kevin Brady, Gerard Bruin, et al.
Therapeutic Advances in Chronic Disease|April 22, 2024
Untimely surgery for stent-fracture-related death after transjugular intrahepatic portosystemic shunt: a case reportYunjiang Li, Junhui Sun, Tanyang Zhou, et al.
Journal of Diabetes Research|February 25, 2021
Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic NephropathyYan Li, Lei Wang, Bojun Xu, et al.
ACS Nano|January 17, 2025
PEGylated Ultrasmall Iron Oxide Nanoparticles as MRI Contrast Agents for Vascular Imaging and Real-Time MonitoringKuan Lu, Ruru Zhang, Hongzhao Wang, et al.
Journal of Nanobiotechnology|January 20, 2026
Injectable multi-component hydrogels for the treatment of ascites caused by hepatocellular carcinoma via anti-tumor and reduction of ascites generationYuqin Yang, Jinchai Qi, Yingqi Lang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|September 15, 2025
Hypertension and BMI as Mediators of Type 2 Diabetes-Induced CKD: Insights from an Integrative Multi-Database StudyHeng Wang, Keyi Fan, Yijie Ning, et al.
Mabs|December 9, 2014
Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case studyKun Peng, Keyang Xu, Luna Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2015
Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody-Drug Conjugate as a Therapeutic for Non-Small Cell Lung and Ovarian CancersKedan Lin, Bonnee Rubinfeld, Crystal Zhang, et al.
Pageof 10